|
|
Antwerp, 8 February 2021, 18:00 Regulated information
Share buyback
In accordance with the announcement on 29 January 2021 of the share buyback in the context of a
share purchase plan for employees, Gimv purchased 40,000 own shares during the period from 1
February to 8 February 2021.... See more |
|
| |
|
| |
|
|
Antwerp, 29 January 2021, 7:30 am
Gimv announces share buyback in the context of a share purchase plan
for its personnel
The Board of Directors of Gimv has decided, in application of Art. 7:215, §1, al. 3 of the Companies
Code, to start a share buyback program of 40,000 shares in the framework of a share purchase plan
for certain Gimv employees. Gimv... See more |
|
| |
|
| |
|
|
Antwerp, 19 January 2021, 14:30 CET
Gimv sells OTN Systems, a provider of telecommunication solutions
for industrial markets, to listed Belden Inc.
Gimv, coshareholders Manuardeo and management, today announce that they are selling OTN
Systems to USbased Belden Inc., a global provider of telecommunication transmission and
security solutions for corporate... See more |
|
| |
|
| |
|
|
Antwerp BE / Schiedam NL, 2 December 2020, 7:30 CET EMBARGO
Gimv sells Itho DaalderopClimate for Life Dutch market leader in
integrated sustainable solutions for energyneutral living in the Benelux
to Parcom
Producer Itho Daalderop and service provider Klimaatgarant today announce an important step in their
development. Gimv will sell its majority... See more |
|
| |
|
| |
|
|
Antwerp BE / Medfield, MA US, 30 November 2020, 8:00 AM CET
Gimv is founding investor of Kinaset Therapeutics in a USD 40m series A
round – funds used to develop novel therapeutics for respiratory
diseases
Gimv invests in Kinaset Therapeutics alongside 5AM Ventures and Atlas Venture in a USD 40m Series A
round to support the clinical development of... See more |
|
| |
|
| |
|
|
Search :
